Patents by Inventor Mark L. Witten

Mark L. Witten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9719985
    Abstract: A method uses an Dioleoylphosphatidylcholine (DOPC) surfactant based bio film that reacts with a material in a known manner, and a device that utilizes such a biofilm, to detect material of interest is provided. The principles of the present invention are particularly useful in detecting/measuring a material.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: August 1, 2017
    Assignee: THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventor: Mark L. Witten
  • Patent number: 8628625
    Abstract: A method that uses an L-?-dipalmitoleoyl-phosphatidylcholine (DPPC) surfactant based device that reacts with a substance in a known manner, to detect a substance of interest or to extract a substance of interest from a material is provided. The principles of the present invention are particularly useful in detecting/measuring a substance that is harmful to a human, and also to extracting NACL from saltwater.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: January 14, 2014
    Inventor: Mark L. Witten
  • Publication number: 20120135398
    Abstract: A method that uses an (DOPC) surfactant based biofilm that reacts with a material in a known manner, and a device that utilizes such a biofilm, to detect a material of interest is provided. The principles of the present invention are particularly useful in detecting/measuring a material that is harmful to a human or to property.
    Type: Application
    Filed: August 2, 2010
    Publication date: May 31, 2012
    Inventor: Mark L. Witten
  • Publication number: 20100267616
    Abstract: Substance P or its analogs are useful for treating and protecting against acute respiratory syndromes including ARDS and SARS. The active agents can be administered via inhalation therapy, intravenously, intramuscularly, sublingually, or by other methods. Disease indicia are reduced by substance P treatment.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Applicant: ImmuneRegen Biosciences, Inc.
    Inventor: Mark L. Witten
  • Publication number: 20100216118
    Abstract: A method that uses an L-?-dipalmitoleoyl-phosphatidylcholine (DPPC) surfactant based device that reacts with a substance in a known manner, to detect a substance of interest or to extract a substance of interest from a material is provided. The principles of the present invention are particularly useful in detecting/measuring a substance that is harmful to a human, and also to extracting NACL from saltwater.
    Type: Application
    Filed: October 1, 2007
    Publication date: August 26, 2010
    Inventor: Mark L. Witten
  • Publication number: 20090286744
    Abstract: Substance P or its analogs are useful for treating asthma. The active agents can be administered orally, intravenously, intramuscularly, intranasally, topically. Disease severity is reduced by substance P treatment.
    Type: Application
    Filed: March 31, 2006
    Publication date: November 19, 2009
    Applicant: IMMUNEREGEN BIOSCINECES INC.
    Inventor: Mark L. Witten
  • Publication number: 20080318869
    Abstract: Wound healing is impaired in irradiated animals. Substance P and its active analogs promote wound healing in irradiated animals. Substance P and its analogs can be used to treat animals irradiated by a nuclear weapon, a nuclear accident, or a therapeutic regimen, for example. Wounds which are susceptible to such treatment include surgical wounds, weapons wounds, disease-caused wounds, bed sores, diabetic ulcers, etc.
    Type: Application
    Filed: October 25, 2005
    Publication date: December 25, 2008
    Applicant: IMMUNEREGEN BIOSCIENCES, INC.
    Inventor: Mark L. Witten
  • Publication number: 20080194487
    Abstract: Substance P or its analogs are useful for treating certain skin diseases. The active agents can be administered topically. Disease severity is reduced by substance P treatment.
    Type: Application
    Filed: December 15, 2005
    Publication date: August 14, 2008
    Inventor: Mark L. Witten
  • Publication number: 20080193403
    Abstract: Hair pigment loss is treated by administration of Substance P or a bioactive analog thereof. The subject may have pigment loss in hair due to any of a variety of reasons, including drug side effects, genetic composition, aging, or nutritional deficit. The treatment can be conveniently administered topically. Maintenance or increasing the amount of hair color results from the treatments.
    Type: Application
    Filed: April 18, 2005
    Publication date: August 14, 2008
    Applicant: IMMUNEREGEN BIOSCIENCES, INC
    Inventor: Mark L. Witten
  • Publication number: 20080167248
    Abstract: Substance P or its analogs can be administered to humans to reverse or retard the course of various biological processes related to aging in adults. Reversal or retardation can be observed in hair color, muscle or joint pain, memory loss, sleep pattern, and visual accommodation.
    Type: Application
    Filed: April 18, 2005
    Publication date: July 10, 2008
    Applicant: IMMUNEREGEN BIOSCIENCES, INC.
    Inventor: Mark L. Witten
  • Patent number: 5998376
    Abstract: Substance P aerosols are effective in replenishing immune systems compromised by environmental toxicants. They are also useful for prophylaxis against and treatment of infections and neoplasms. They are useful for accelerating maturation of immune systems or maintaining immune function, as well. Chronic exposure to hydrocarbons is particularly damaging to the immune system, and thus this occupational hazard can be counteracted by treatment with substance P aerosols.
    Type: Grant
    Filed: February 23, 1998
    Date of Patent: December 7, 1999
    Inventors: Mark L. Witten, David T. Harris
  • Patent number: 5945508
    Abstract: Substance P aerosols are effective in replenishing immune systems compromised by environmental toxicants. They are also useful for prophylaxis against and treatment of infections and neoplasms. They are useful for accelerating maturation of immune systems or maintaining immune function, as well. Chronic exposure to hydrocarbons is particularly damaging to the immune system, and thus this occupational hazard can be counteracted by treatment with substance P aerosols.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: August 31, 1999
    Inventors: Mark L. Witten, David T. Harris